Drug Price Hikes Cost Americans Billions Of Dollars, Report Says

A report by the Institute for Clinical and Economic Reviews highlights significant price increases for seven popular drugs from 2017 to 2018, despite lacking clinical evidence to justify these hikes. The report identifies drugs like Humira and Lyrica, noting that the price increases cost patients and insurers billions. Drug manufacturers dispute the report's methodology, while Congress considers pricing plans that could save taxpayers billions on Medicaid and Medicare.

What was the average price increase percentage for Humira from 2017?

What are the two drug pricing plans currently competing in Congress aimed at?